Expansive Healthcare Reach Huma's technology has been deployed across over 3,000 hospitals and clinics in more than 70 countries, engaging over 35 million individuals. This extensive global footprint presents opportunities to collaborate with healthcare providers and government agencies seeking proven digital health solutions.

Regulatory Approvals With FDA 510(k), EU/MDR Class IIb, and Saudi FDA Class C clearances, Huma’s platform demonstrates strong regulatory compliance, easing the path for adoption in various international markets and appealing to healthcare organizations prioritizing compliance.

Growth in Digital Health Huma’s focus on AI-driven healthcare solutions and its ability to host AI and machine learning models offer significant value for health systems aiming to enhance patient engagement, remote monitoring, and research capabilities through innovative technology.

Strategic Industry Positioning The company’s collaborations with major pharmaceutical companies, CROs, and participation in national health projects indicate a solid foothold in both clinical research and care delivery sectors, providing multiple avenues for new partnerships in research and medication management.

Funding and Market Potential With $130 million in funding and revenues estimated between 50 to 100 million dollars, Huma shows strong financial backing and growth potential, making it a compelling partner for organizations seeking scalable, innovative digital health solutions with market expansion prospects.